Q2 2024 |
9 |
$90.8M |
+$24.8M |
-$33.4M |
-$8.6M |
BLDR, SNBR, GDDY, BC, DV
|
13F-HR |
8/14/2024, 04:07 PM |
Q1 2024 |
9 |
$126M |
+$22.9M |
-$28.3M |
-$5.4M |
BLDR, SNBR, GDDY, ZI, DV
|
13F-HR |
5/15/2024, 04:03 PM |
Q4 2023 |
8 |
$119M |
+$20.1M |
-$27.3M |
-$7.19M |
SNBR, BLDR, GDDY, PGTI, RH
|
13F-HR |
2/14/2024, 04:06 PM |
Q3 2023 |
10 |
$121M |
+$38M |
-$27.2M |
+$10.9M |
SNBR, GDDY, PGTI, BLDR, RH
|
Restatement |
12/15/2023, 11:56 AM |
Q2 2023 |
13 |
$116M |
+$13.3M |
-$69.5M |
-$56.1M |
GDDY, PGTI, SNBR, BLDR, TNET
|
Restatement |
8/23/2023, 05:20 PM |
Q1 2023 |
1 |
$3.17M |
$0 |
$0 |
|
GTLB
|
New Holdings |
5/16/2023, 04:21 PM |
Q1 2023 |
10 |
$147M |
+$2.72M |
-$23.6M |
-$20.9M |
PGTI, BLDR, GDDY, SNBR, TNET
|
13F-HR |
5/15/2023, 11:05 AM |
Q4 2022 |
11 |
$147M |
+$14.7M |
-$28M |
-$13.4M |
PGTI, GDDY, BLDR, SNBR, FXLV
|
13F-HR |
2/14/2023, 12:16 PM |
Q3 2022 |
11 |
$168M |
+$22.1M |
-$55.3M |
-$33.3M |
PGTI, GDDY, SNBR, BLDR, GTLB
|
13F-HR |
11/14/2022, 11:10 AM |
Q2 2022 |
10 |
$184M |
+$50.7M |
-$43.7M |
+$6.99M |
GDDY, BLDR, PGTI, SNBR, EME
|
13F-HR |
8/15/2022, 12:02 PM |
Q1 2022 |
10 |
$211M |
+$52M |
-$75.4M |
-$23.4M |
GDDY, SNBR, PGTI, LOPE, BLDR
|
13F-HR |
5/16/2022, 10:44 AM |
Q4 2021 |
10 |
$266M |
+$38M |
-$20.7M |
+$17.3M |
LOPE, WW, GDDY, BLDR, THFF
|
13F-HR |
2/14/2022, 09:38 AM |
Q3 2021 |
11 |
$229M |
+$83M |
-$28.7M |
+$54.3M |
WW, LOPE, GDDY, THFF, BLDR
|
13F-HR |
11/15/2021, 01:29 PM |
Q2 2021 |
11 |
$207M |
+$41.3M |
-$53.4M |
-$12.1M |
WW, LOPE, THFF, EME, BLDR
|
13F-HR |
8/16/2021, 04:38 PM |
Q1 2021 |
10 |
$214M |
+$20.1M |
-$46.5M |
-$26.4M |
WW, EME, LOPE, THFF, GDDY
|
13F-HR |
5/17/2021, 04:17 PM |
Q4 2020 |
9 |
$200M |
+$32.1M |
-$92.4M |
-$60.3M |
WW, EME, LOPE, THFF, UVE
|
13F-HR |
2/16/2021, 01:21 PM |
Q3 2020 |
14 |
$211M |
+$38.8M |
-$94.9M |
-$56.2M |
EME, WW, BLDR, LOPE, WSFS
|
13F-HR |
11/16/2020, 01:13 PM |
Q2 2020 |
13 |
$249M |
+$58.9M |
-$45.3M |
+$13.6M |
BLDR, WW, EME, UVE, THFF
|
13F-HR |
8/14/2020, 04:34 PM |
Q1 2020 |
14 |
$176M |
+$142M |
-$4.44M |
+$138M |
WW, BLDR, LOPE, EME, UVE
|
13F-HR |
5/15/2020, 01:42 PM |
Q4 2019 |
8 |
$74M |
+$12.3M |
-$127M |
-$114M |
GRBK, CRHM, UVE, BLDR, ASNAQ
|
13F-HR |
2/14/2020, 12:43 PM |
Q3 2019 |
10 |
$166M |
+$15.2M |
-$68.4M |
-$53.2M |
BLDR, GRBK, CRHM, CARB, WW
|
13F-HR |
11/14/2019, 12:45 PM |
Q2 2019 |
11 |
$217M |
+$45.5M |
-$20M |
+$25.6M |
BLDR, CARB, WW, CRHM, GRBK
|
13F-HR |
8/14/2019, 01:30 PM |
Q1 2019 |
14 |
$188M |
+$41M |
-$78M |
-$37.1M |
BLDR, ASNA, WW, SFLY, GRBK
|
13F-HR |
5/15/2019, 12:40 PM |
Q4 2018 |
15 |
$242M |
+$60.7M |
-$22M |
+$38.6M |
BLDR, CIVI, ASNA, SFLY, CLUBQ
|
13F-HR |
2/14/2019, 10:38 AM |
Q3 2018 |
12 |
$260M |
+$34.3M |
-$7.77M |
+$26.5M |
ASNA, BLDR, CIVI, TBRG, CLUBQ
|
13F-HR |
11/14/2018, 12:38 PM |
Q2 2018 |
10 |
$247M |
+$10.1M |
-$32.3M |
-$22.2M |
ASNA, BLDR, CIVI, TBRG, CLUBQ
|
13F-HR |
8/14/2018, 12:04 PM |
Q1 2018 |
12 |
$223M |
+$56.7M |
-$6.12M |
+$50.6M |
BLDR, CIVI, ASNA, TBRG, ACIC
|
13F-HR |
5/15/2018, 11:52 AM |
Q4 2017 |
10 |
$184M |
+$19.2M |
-$97M |
-$77.8M |
BLDR, ASNA, CIVI, TBRG, ACIC
|
13F-HR |
2/14/2018, 10:35 AM |
Q3 2017 |
11 |
$243M |
+$11.7M |
-$22.7M |
-$11M |
BLDR, TBRG, ASNA, CIVI, ACIC
|
13F-HR |
11/14/2017, 10:22 AM |
Q2 2017 |
12 |
$233M |
+$12M |
-$7.56M |
+$4.46M |
BLDR, TBRG, ASNA, CIVI, UTI
|
13F-HR |
8/11/2017, 07:00 PM |
Q1 2017 |
7 |
$251M |
$0 |
-$46.7M |
-$46.7M |
BLDR, ASNA, TBRG, CIVI, UTI
|
13F-HR |
5/12/2017, 10:23 AM |
Q4 2016 |
9 |
$288M |
+$37.5M |
-$80.2M |
-$42.7M |
BLDR, ASNA, TBRG, CIVI, BGFV
|
13F-HR |
2/10/2017, 10:42 AM |
Q3 2016 |
11 |
$309M |
+$35.3M |
-$25.9M |
+$9.44M |
BLDR, ASNA, BGFV, TBRG, EXPR
|
13F-HR |
11/14/2016, 10:44 AM |
Q2 2016 |
12 |
$309M |
+$59.7M |
-$20.8M |
+$38.9M |
ASNA, BLDR, BGFV, EXPR, BKE
|
13F-HR |
8/15/2016, 12:30 PM |
Q1 2016 |
11 |
$330M |
+$107M |
-$57.1M |
+$49.5M |
ASNA, BLDR, BGFV, POLY, UTI
|
13F-HR |
5/12/2016, 11:21 AM |
Q4 2015 |
11 |
$263M |
+$35.7M |
-$12.7M |
+$23M |
ASNA, BLDR, NSP, BGFV, UTI
|
13F-HR |
2/12/2016, 11:52 AM |
Q3 2015 |
11 |
$273M |
+$55.6M |
-$65.8M |
-$10.2M |
ASNA, NSP, BLDR, BGFV, UTI
|
13F-HR |
11/13/2015, 11:48 AM |
Q2 2015 |
11 |
$340M |
+$2.09M |
-$136M |
-$134M |
BLDR, ASNA, NSP, BGFV, UTI
|
13F-HR |
8/13/2015, 02:50 PM |
Q1 2015 |
12 |
$383M |
+$9.01M |
-$80.2M |
-$71.1M |
ASNA, BLDR, NSP, EXPR, UTI
|
13F-HR |
5/14/2015, 11:40 AM |
Q4 2014 |
12 |
$399M |
+$56.1M |
-$17.1M |
+$38.9M |
BLDR, NSP, ASNA, EXPR, BGFV
|
13F-HR |
2/13/2015, 03:31 PM |
Q3 2014 |
12 |
$315M |
+$30.5M |
-$15.3M |
+$15.2M |
BLDR, ASNA, NSP, UTI, EXPR
|
13F-HR |
11/13/2014, 02:52 PM |
Q2 2014 |
11 |
$375M |
+$62.8M |
-$14.2M |
+$48.6M |
BLDR, NSP, ASNA, UTI, EXPR
|
13F-HR |
8/13/2014, 11:32 AM |
Q1 2014 |
12 |
$352M |
+$16.7M |
-$18.8M |
-$2.02M |
BLDR, NSP, UTI, BGFV, ASNA
|
13F-HR |
5/14/2014, 10:49 AM |
Q4 2013 |
12 |
$357M |
$0 |
$0 |
|
BLDR, NSP, UTI, BGFV, ASNA
|
13F-HR |
2/13/2014, 07:13 PM |